These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21794064)

  • 21. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
    Hakimi AA; Ghavamian R
    Urol Clin North Am; 2011 Nov; 38(4):407-18, v. PubMed ID: 22045172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node assessment and lymphadenectomy in bladder cancer.
    Sharir S; Fleshner NE
    J Surg Oncol; 2009 Mar; 99(4):225-31. PubMed ID: 19235178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results.
    Mills RD; Fleischmann A; Studer UE
    Surg Oncol Clin N Am; 2007 Jan; 16(1):233-45. PubMed ID: 17336246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report.
    Herr H; Lee C; Chang S; Lerner S;
    J Urol; 2004 May; 171(5):1823-8; discussion 1827-8. PubMed ID: 15076285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic lymphadenectomy during radical cystectomy: a review of the literature.
    Hurle R; Naspro R
    Surg Oncol; 2010 Dec; 19(4):208-20. PubMed ID: 19500973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
    Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
    J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.
    Bruins HM; Stein JP
    Expert Rev Anticancer Ther; 2008 Jul; 8(7):1091-101. PubMed ID: 18588454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.
    Jeong IG; Park J; Song K; Ro JY; Song C; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2011; 29(2):199-204. PubMed ID: 19556153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pelvic lymphatic excision using laparoscopy. Its value in the staging of tumors of the bladder].
    Antiphon P; Chopin DK; Bellot J; Barthélémy Y; Abbou CC
    Ann Urol (Paris); 1993; 27(1):12-9. PubMed ID: 8470874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer.
    Nagele U; Anastasiadis AG; Merseburger AS; Sievert KD; Stenzl A; Kuczyk M
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):871-6. PubMed ID: 16761930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma.
    Copp HL; Chin JL; Conaway M; Theodorescu D
    Cancer; 2006 Jul; 107(1):60-6. PubMed ID: 16691580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognostic factors of invasive bladder cancer with lymph node invasion].
    Lacroix B; Rusch P; Cerisier A; Pages A; Armand C; Tostain J
    Prog Urol; 2002 Sep; 12(4):615-20. PubMed ID: 12463120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard.
    Raj GV; Bochner BH
    Semin Oncol; 2007 Apr; 34(2):110-21. PubMed ID: 17382794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extranodal extension in node-positive bladder cancer: the continuing controversy.
    Jeong IG; Ro JY; Kim SC; You D; Song C; Hong JH; Ahn H; Kim CS
    BJU Int; 2011 Jul; 108(1):38-43. PubMed ID: 21070576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens.
    Resnick MJ; Bergey M; Magerfleisch L; Tomaszewski JE; Malkowicz SB; Guzzo TJ
    BJU Int; 2011 Jan; 107(1):46-52. PubMed ID: 20880163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.